376 related articles for article (PubMed ID: 3173937)
1. The effects of estradiol on blood lipids and lipoproteins in postmenopausal women.
Fåhraeus L
Obstet Gynecol; 1988 Nov; 72(5 Suppl):18S-22S. PubMed ID: 3173937
[TBL] [Abstract][Full Text] [Related]
2. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
3. Women, lipoproteins and cardiovascular disease risk.
LaRosa JC
Can J Cardiol; 1990 May; 6 Suppl B():23B-29B. PubMed ID: 2188715
[TBL] [Abstract][Full Text] [Related]
4. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.
Ylikorkala O; Lim P; Caubel P
Clin Ther; 2000 May; 22(5):622-36. PubMed ID: 10868559
[TBL] [Abstract][Full Text] [Related]
5. Changes in lipoproteins with various sex steroids.
Teran AZ; Greenblatt RB; Chaddha JS
Obstet Gynecol Clin North Am; 1987 Mar; 14(1):107-19. PubMed ID: 3306515
[TBL] [Abstract][Full Text] [Related]
6. Effect of continuous combined estrogen and desogestrel hormone replacement therapy on serum lipids and lipoproteins.
Marsh MS; Crook D; Whitcroft SI; Worthington M; Whitehead MI; Stevenson JC
Obstet Gynecol; 1994 Jan; 83(1):19-23. PubMed ID: 8272301
[TBL] [Abstract][Full Text] [Related]
7. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
[TBL] [Abstract][Full Text] [Related]
8. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
[TBL] [Abstract][Full Text] [Related]
9. Effect of estrogen replacement therapy on lipids. Implications for cardiovascular risk.
LaRosa JC
J Reprod Med; 1985 Oct; 30(10 Suppl):811-3. PubMed ID: 4078813
[TBL] [Abstract][Full Text] [Related]
10. [Women and ischemic cardiopathy].
Assmann G; Davignon J; Fernández Cruz A; Gotto AM; Jacotot B; Lewis B; Paoletti R
Rev Clin Esp; 1989 Oct; 185(6):308-15. PubMed ID: 2695994
[TBL] [Abstract][Full Text] [Related]
11. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
[TBL] [Abstract][Full Text] [Related]
13. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH
Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668
[TBL] [Abstract][Full Text] [Related]
14. Oral contraceptives and lipoprotein metabolism.
Tikkanen MJ; Nikkilä EA
J Reprod Med; 1986 Sep; 31(9 Suppl):898-905. PubMed ID: 3772909
[TBL] [Abstract][Full Text] [Related]
15. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy.
Hirvonen E; Mälkönen M; Manninen V
N Engl J Med; 1981 Mar; 304(10):560-3. PubMed ID: 7453723
[TBL] [Abstract][Full Text] [Related]
16. Effects of oral contraceptives on circulating lipids and lipoproteins: maximizing benefit, minimizing risk.
LaRosa JC
Int J Fertil; 1989; 34 Suppl():71-84. PubMed ID: 2576264
[TBL] [Abstract][Full Text] [Related]
17. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
Rozenberg S; Ylikorkala O; Arrenbrecht S
Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
[TBL] [Abstract][Full Text] [Related]
18. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Teichmann A
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
[TBL] [Abstract][Full Text] [Related]
19. Lipid and lipoprotein changes in relation to oral contraception and hormonal replacement therapy.
Burkman RT
Fertil Steril; 1988 May; 49(5 Suppl 2):39S-50S. PubMed ID: 3282934
[TBL] [Abstract][Full Text] [Related]
20. Atherogenesis: why women live longer than men.
Hazzard WR
Geriatrics; 1985 Jan; 40(1):42-51, 54. PubMed ID: 3965355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
